Melanoma: all 3,073 studies
Page 4 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- FMT in Checkpoint Inhibitor-mediated Diarrhea and ColitisRecruitingNCT06206707Not applicable
- To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic MelanomaRecruitingNCT06204991Phase 1
- Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma PatientsRecruitingNCT06199713
- Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaRecruitingNCT06194929Phase 1/2
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma PatientsRecruitingNCT06154668
- A Phase 1 of CTX-8371 in Patients With Advanced MalignanciesRecruitingNCT06150664Phase 1
- Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable ResponseRecruitingNCT06116461Phase 4
- Investigating Participation Patterns Among Stage IV Melanoma PatientsNot yet recruitingNCT06093594
- A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsRecruitingNCT06090266Phase 1/2
- A Study of IBI363 in Subjects With Advanced MelanomaRecruitingNCT06081920Phase 2
- AI-Augmented Skin Cancer Diagnosis in TeledermatoscopyEnrolling by invitationNCT06080711Not applicable
- Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer TypesRecruitingNCT06075524
- Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method StudyNot yet recruitingNCT06073548
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingRecruitingNCT06066138Phase 1
- Safety and Efficacy of OBX-115 in Advanced Solid TumorsRecruitingNCT06060613Phase 1/2
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal MelanomaNot yet recruitingNCT06041724Phase 2
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.RecruitingNCT06022029Phase 1
- Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant MelanomaRecruitingNCT06008106Phase 3
- Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced MelanomaRecruitingNCT05983237Phase 1/2
- A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsRecruitingNCT05970497Phase 1/2
- Naltrexone and Propranolol Combined With ImmunotherapyRecruitingNCT05968690Phase 1
- Versatile Ampification Single-Molecule Detection in Liquid BiopsyRecruitingNCT05940311
- An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant MelanomasEnrolling by invitationNCT05928962Phase 1
- A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsRecruitingNCT05914116Phase 1/2
- Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaRecruitingNCT05907512Phase 2
- Biobanking and New Biomolecular MetricsRecruitingNCT05906277Not applicable
- Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver MetastasesNot yet recruitingNCT05903937Phase 1
- Perioperative Treatment With Tranexamic Acid in MelanomaRecruitingNCT05899465Phase 3
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerRecruitingNCT05896839Phase 1/2
- Melphalan Chemoreduction for Ocular MelanomaEnrolling by invitationNCT05893654Phase 1/2
- Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal MelanomaRecruitingNCT05889481
- Biomarkers in Immunotherapy of MelanomaRecruitingNCT05878977Not applicable
- OH2 Injection in MelanomaRecruitingNCT05868707Phase 3
- Blocking TNF to Potentiate the ICI-dependent Immune Awakening in MelanomaRecruitingNCT05867004
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 1
- Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1RecruitingNCT05856565
- Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.Not yet recruitingNCT05854589Phase 2
- Excision of Lymph Node Trial (EXCILYNT) (Mel69)RecruitingNCT05839912Not applicable
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable
- Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell CarcinomaRecruitingNCT05830058Phase 2
- 'Cancer Patients Better Life Experience'RecruitingNCT05827289Not applicable
- Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral MelanomaRecruitingNCT05789043Phase 3
- Cryoablation+Ipilimumab+Nivolumab in MelanomaRecruitingNCT05779423Phase 2
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.RecruitingNCT05770544Phase 2/3
- DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) DispositionRecruitingNCT05770102Phase 2/3
- DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.RecruitingNCT05768178Phase 2/3
- (Neo)Adjuvant BRAF/MEK Inhibition in pN1c MelanomaRecruitingNCT05767879Phase 2
- Retrospective Register for Uveal MelanomaRecruitingNCT05733728
- Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.RecruitingNCT05727904Phase 3
- KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced MelanomaRecruitingNCT05723432Phase 1/2
- Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain MetastasesRecruitingNCT05704647Phase 2
- Spanish Academy of Dermatology and Venereology (AEDV) Melanoma RegistryRecruitingNCT05673681
- Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant MelanomaNot yet recruitingNCT05664139Phase 2
- MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced MelanomaRecruitingNCT05655312Phase 1/2
- Safe Stop Ipilimumab-nivolumab (IPI-NIVO) TrialRecruitingNCT05652673Not applicable
- Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint InhibitorsRecruitingNCT05649683Not applicable
- A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the LiverNot yet recruitingNCT05647954Phase 3
- LIVInG With chrONic Cancer TrEatments (LONGEVITI) StudyRecruitingNCT05645510
- Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic MelanomaNot yet recruitingNCT05641012
- Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint InhibitorsRecruitingNCT05629546Phase 1
- MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin CancerRecruitingNCT05620290Phase 1
- A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or AngiosarcomaRecruitingNCT05607095Phase 1
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentEnrolling by invitationNCT05600933
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the BrainRecruitingNCT05588453Phase 1/2
- Metabolic Phenotypes in MelanomaRecruitingNCT05570227Not applicable
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)RecruitingNCT05549297Phase 3
- Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable MelanomaNot yet recruitingNCT05539118Phase 1/2
- Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected MelanomaRecruitingNCT05527795
- Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung CancerRecruitingNCT05522660Phase 3
- Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral MelanomaRecruitingNCT05512481Phase 2
- Adjuvant Melatonin for Uveal MelanomaRecruitingNCT05502900Phase 3
- PD-1 Inhibitors With or Without Radiation in Advanced MelanomaNot yet recruitingNCT05498805Phase 2
- Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in MelanomaRecruitingNCT05498792Early Phase 1
- START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerRecruitingNCT05492682Phase 1
- Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital TractRecruitingNCT05478876Not applicable
- Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced MelanomaRecruitingNCT05478473Not applicable
- PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced MelanomaRecruitingNCT05466474Phase 2
- BioMEL- Diagnostic and Prognostic Factors in Melanoma.RecruitingNCT05446155
- Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in MelanomaRecruitingNCT05429138
- Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV MelanomaRecruitingNCT05428007Phase 2
- A Study of TRK-950 in Patients With Advanced Solid TumorsRecruitingNCT05423262Phase 1/2
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical PracticeRecruitingNCT05402059
- Expanded Access Program of AMTAGVI That is Out of Specification for Commercial ReleaseAvailableNCT05398640
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT05379985Phase 1/2
- MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsRecruitingNCT05373823Not applicable
- A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerRecruitingNCT05361174Phase 1/2
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in MelanomaRecruitingNCT05307289Not applicable
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersRecruitingNCT05296564Phase 1/2
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerRecruitingNCT05267626Phase 1/2
- HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K MutationRecruitingNCT05263453Phase 2
- The MELAcare Study: A New Method for Surveillance of Melanoma PatientsRecruitingNCT05253872Not applicable
- FMT to Convert Response to ImmunotherapyRecruitingNCT05251389Phase 1/2
- Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable DiseaseRecruitingNCT05229614Phase 2